||**Tiny Steps**<br>|**Tiny Steps**<br>|**Tiny Steps**<br>|**1161146**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|1st October 2024|**To**|30th September 2025||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**29,366.94**<br>**1,587**<br>**141**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **31,095**<br>**-**<br>**-**<br> **-**<br> **31,095**<br>**-**<br>**£0**<br>**199.12**<br>**18,071.75**<br>**£0**<br>**-**<br>**-**<br>**-**<br> **18,271**<br>**-**<br>**-**<br> **-**<br>**18,271**<br>**12,824**<br>**-**<br>**247,706**<br>**260,530**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**29,367**<br>**1,587**<br>**141**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**31,095**<br>**-**<br>**-**<br>**-**<br>**31,095**<br>**-**<br>**-**<br>**199**<br>**-**<br>**18,072**<br>**-**<br>**-**<br>**-**<br>**-**<br>**18,271**<br>**-**<br>**-**<br>**-**<br>**18,271**<br>**-**<br> **12,824**<br>**-**<br>**247,706**<br>**260,530**|**Last year**<br>**to the nearest £**|
|Voluntary Receipts|**29,366.94**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**29,367**|**38,961**|
|Accounts payable|**1,587**|||**1,587**|**-**|
|Interest|**141**|||**141**|**-**|
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**31,095**|||**31,095**|**38,961**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
||**-**||**-**<br>**-**<br>**-**|**-**||
||**-**|||**-**|**-**|
|**_Sub total_**|**-**|||**-**|**-**|
|**_Total receipts_ **<br>**A3 Payments**||||||
||||**-**|**31,095**|**38,961**|
|||||||
|Cost of Fundraising Events|**-**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**||
|Advertising|**£0**|||**-**|**-**|
|Bank Interest and Other Charges|**199.12**|||**199**|**533**|
|Consultancy||||**-**|**-**|
|Stay & Play|**18,071.75**|||**18,072**|**19,696**|
|Insurance|**£0**|||**-**||
|Other|**-**|||**-**||
||**-**|||**-**|**-**|
||**-**|||**-**|**-**|
|**_Sub total_ **|**18,271**|||**18,271**|**20,229**|
|||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||
||**-**||**-**<br>**-**<br>**-**|**-**||
||**-**|||**-**||
|**_Sub total_ **|**-**|||**-**|**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||||**-**|**18,271**|**20,229**|
|||||**-**||
||**12,824**|**-**|**-**|**12,824**|**18,732**|
||**-**|**-**|**-**<br>**-**|**-**|**-**|
||**247,706**|**-**||**247,706**|**228,974**|
||**260,530**|**-**|**-**|**260,530**|**247,706**|



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**|**Details**<br>**_Total cash funds_**|**Unrestricted**<br>**funds**<br>**to nearest £**|**Restricted funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|
|||**260,530**<br>**-**<br>**-**|**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
|||**260,530**|**-**|**-**|





|Signed by one or two trustees on behalf<br>of all the trustees<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**B2 Other monetary assets**<br>**Details**<br>**B3 Investment assets**<br>**Details**<br>**Details**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>Signature|OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Laura Clifton|OK|
|---|---|---|
|||**Endowment**<br>**funds**<br>**to nearest £**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**Current value**<br>**(optional)**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**Current value**<br>**(optional)**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**-**|
|||**When due**<br>**(optional)**|
||||
||||
||||
||||
||||
||||
|||Date of<br>approval|
||Laura Clifton||
||||



